Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical exporter from India, delivering high-quality Mounjaro Injection 7.5 mg (Tirzepatide) with fast and reliable international shipping. We supply to healthcare distributors, pharmacies, and licensed importers across United States, United Kingdom, France, Germany, Switzerland, Belgium, Singapore, UAE, Saudi Arabia, Nigeria, Kenya, South Africa, Vietnam, Philippines, Indonesia, Brazil, and Mexico.
About Mounjaro Injection 7.5 mg
Mounjaro (Tirzepatide) is an advanced once-weekly injectable medication used for improving blood sugar control in adults with Type 2 Diabetes Mellitus and is also widely used under medical supervision for weight management support.
Usage
Management of Type 2 Diabetes Mellitus
Helps regulate blood glucose levels
Supports appetite control and weight reduction (as prescribed by physician)
Administered as a subcutaneous injection once weekly
Dosage Information
Starting dose: 2.5 mg once weekly (initial phase)
Maintenance dose: 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly depending on patient response
Mounjaro 7.5 mg is commonly used as a maintenance escalation dose
Dosage must always be determined by a licensed healthcare professional
Side Effects
Common side effects may include:
Nausea
Vomiting
Diarrhea or constipation
Reduced appetite
Abdominal discomfort
Serious (rare) side effects:
Pancreatitis
Gallbladder issues
Low blood sugar (especially with insulin or sulfonylureas)
Possible thyroid-related warnings (as observed in animal studies)
Global Export & Supply
Cordium Pharmaceuticals Pvt Ltd ensures:
Certified pharmaceutical-grade sourcing
Secure cold-chain or temperature-controlled logistics (as required)
Fast worldwide delivery network
Export compliance documentation support
Bulk supply for distributors and wholesalers
We are committed to providing reliable pharmaceutical export solutions from India to global markets.
Contact for Export Inquiry
š± WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
About Mounjaro Injection 7.5 mg
Mounjaro (Tirzepatide) is an advanced once-weekly injectable medication used for improving blood sugar control in adults with Type 2 Diabetes Mellitus and is also widely used under medical supervision for weight management support.
Usage
Management of Type 2 Diabetes Mellitus
Helps regulate blood glucose levels
Supports appetite control and weight reduction (as prescribed by physician)
Administered as a subcutaneous injection once weekly
Dosage Information
Starting dose: 2.5 mg once weekly (initial phase)
Maintenance dose: 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly depending on patient response
Mounjaro 7.5 mg is commonly used as a maintenance escalation dose
Dosage must always be determined by a licensed healthcare professional
Side Effects
Common side effects may include:
Nausea
Vomiting
Diarrhea or constipation
Reduced appetite
Abdominal discomfort
Serious (rare) side effects:
Pancreatitis
Gallbladder issues
Low blood sugar (especially with insulin or sulfonylureas)
Possible thyroid-related warnings (as observed in animal studies)
Global Export & Supply
Cordium Pharmaceuticals Pvt Ltd ensures:
Certified pharmaceutical-grade sourcing
Secure cold-chain or temperature-controlled logistics (as required)
Fast worldwide delivery network
Export compliance documentation support
Bulk supply for distributors and wholesalers
We are committed to providing reliable pharmaceutical export solutions from India to global markets.
Contact for Export Inquiry
š± WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
Keywords
